Tetrahydropalmatine
Tetrahydropalmatine possesses analgesic effects. Tetrahydropalmatine acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1].
Product Specifications
CAS Number
2934-97-6
Product Name Alternative
DL-Tetrahydropalmatine
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Dopamine Receptor
Related Pathways
Apoptosis; GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Purity
99.93
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
COC1=CC=C2C(CN3CCC4=CC(OC)=C(OC)C=C4C3C2)=C1OC
Molecular Formula
C21H25NO4
Molecular Weight
355.43
Precautions
H302, H315, H319, H335
References & Citations
[1]Chang CK, et al. DL-Tetrahydropalmatine may act through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats. Neurosci Lett. 2001 Jul 20;307 (3) :163-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A00040-2-FITC 100 µg/Vial
Anti-Bcl-2/BCL2 Antibody Picoband® (FITC Conjugate)
Sign In for Pricing
View Details 
K1778403 1.0 µg DNA
RAD17P2 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details bsm-62263R-BF488 100 µL
MCM4 Recombinant Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details